common.study.topics.clinical
Multiple Myeloma Molecular Monitoring Study
common.study.values.description
“Multiple Myeloma Molecular Monitoring Study”
The investigators will track 250 multiple myeloma patients across Canada over time, using new lab tests to evaluate their blood and bone marrow, as they receive standard of care treatment. The main hypothesis is that these tests will allow clinicians to better diagnose and manage multiple myeloma, improving patients' quality of life overall.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
common.study.methods.no-methods
participant.views.study.view.additional
participant.views.study.view.scientific-title
The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study
common.study.values.clinical-trial-id
NCT03421132
participant.views.study.view.id
Xe0JVb
